Hematology NewsMonitoring, early intervention key to CAR T safetyApril 24, 2019Cellular TherapyAggressive LymphomasImmunotherapyB Cell LymphomaTransplantationImmuno-oncologyLymphoma & Plasma Cell Disorders
Hematology NewsRIT consolidation may be an option for unfit MCL patientsApril 17, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsBendamustine/rituximab combo proves viable for comorbid CLLApril 10, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell LymphomaRare Diseases
Hematology TimesIn situ vaccination produced responses in indolent NHLApril 8, 2019B Cell LymphomaIndolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsDA-EPOCH-R appears more toxic than standard R-CHOP in DLBCLApril 5, 2019B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsPolatuzumab outperforms pinatuzumab in non-Hodgkin lymphomaApril 5, 2019B Cell LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsEarly data support R-BAC for post-BTKi mantle cell lymphomaApril 5, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsIbrutinib sustained responses in refractory CLL in long-term follow-upMarch 27, 2019CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology NewsRituximab boosts survival in primary CNS lymphomaMarch 22, 2019B Cell LymphomaNeuro-oncologyLymphoma & Plasma Cell Disorders
Hematology NewsHigh survival in relapsed FL after primary radiotherapyMarch 21, 2019Follicular LymphomaLymphoma & Plasma Cell DisordersIndolent LymphomaB Cell Lymphoma
Hematology NewsMCL survival rates improve with novel agentsMarch 20, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsWorse survival seen among black patients with MCLMarch 20, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersPatient & Survivor CareB Cell Lymphoma
Hematology NewsVenetoclax and obinutuzumab induces deep responses in CLLMarch 18, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsShort telomeres predict poorer response to chemo in CLLMarch 15, 2019CLLB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsBendamustine-rituximab shines in frontline treatment of MCL, iNHLMarch 8, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
